Clinical Trial Update: Omission of Local Therapies in Women Patients With HER2-positive or Triple-negative Breast Cancer [Phase 2]

View source ↗

Summary

This document provides a Phase 2 clinical trial update on omitting local therapies in women with HER2-positive or triple-negative breast cancer. The study is cu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Triple-negative Breast Cancer

Snippet

Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | Conditions: Breast Neoplasm Malignant Female | Phase 2 | Status: RECRUITING